Erica A Voss

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Venues

Pharmaceutical medicine

Journal of the American Medical Informatics Association : JAMIA

Drug safety

Clinical epidemiology

Janssen Research & Development

The Pennsylvania State University (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Janssen Research & Development Apr 01 2011

United States

Manager :: Epidemiology Analytics

Education History

The Pennsylvania State University Sep 01 2000 - Dec 31 2004

United States

BSC

Publications

Erica A Voss, Clair Blacketer, Sebastiaan van Sandijk, Maxim Moinat, Michael Kallfelz, Michel van Speybroeck, Daniel Prieto-Alhambra, Martijn J Schuemie, Peter R Rijnbeek
European Health Data & Evidence Network-learnings from building out a standardized international health data network. Journal of the American Medical Informatics Association : JAMIA (2023)
Berta Raventós, Sergio Fernández-Bertolín, Maria Aragón, Erica A Voss, Clair Blacketer, Leonardo Méndez-Boo, Martina Recalde, Elena Roel, Andrea Pistillo, Carlen Reyes, Sebastiaan van Sandijk, Lars Halvorsen, Peter R Rijnbeek, Edward Burn, Talita Duarte-Salles
Transforming the Information System for Research in Primary Care (SIDIAP) in Catalonia to the OMOP Common Data Model and Its Use for COVID-19 Research. Clinical epidemiology 15 (2023)
Rupa Makadia, Azza Shoaibi, Gowtham A Rao, Anna Ostropolets, Peter R Rijnbeek, Erica A Voss, Talita Duarte Salles, Juan Manuel Ramírez-Anguita, Miguel A Mayer, Filip Maljković, Spiros Denaxas, Fredrik Nyberg, Vaclav Papez, Anthony G Sena, Thamir M Alshammari, Lana Y H Lai, Kevin Haynes, Marc A Suchard, George Hripcsak, Patrick B Ryan
Evaluating the impact of alternative phenotype definitions on incidence rates across a global data network. JAMIA open 6 (4) (2023)
Erica A Voss, Saberi Rana Ali, Arun Singh, Peter R Rijnbeek, Martijn J Schuemie, Daniel Fife
Hip Fracture Risk After Treatment with Tramadol or Codeine: An Observational Study. Drug safety 45 (7) (2022)
Marsha A Wilcox, Jill Hardin, James Weaver, Erica A Voss
Liver Test Monitoring: Real-World Compliance for Drugs with Monitoring Requirements at 2-Week Intervals or More Frequently. Pharmaceutical medicine 33 (5) (2020)

Erica A Voss.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Erica A Voss